412 related articles for article (PubMed ID: 18835884)
1. Prostaglandin H2 induces the migration of human eosinophils through the chemoattractant receptor homologous molecule of Th2 cells, CRTH2.
Schuligoi R; Sedej M; Waldhoer M; Vukoja A; Sturm EM; Lippe IT; Peskar BA; Heinemann A
J Leukoc Biol; 2009 Jan; 85(1):136-45. PubMed ID: 18835884
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of the 4-aminotetrahydroquinoline derivatives, selective chemoattractant receptor-homologous molecule expressed on T helper 2 cell antagonists, on eosinophil migration induced by prostaglandin D2.
Mimura H; Ikemura T; Kotera O; Sawada M; Tashiro S; Fuse E; Ueno K; Manabe H; Ohshima E; Karasawa A; Miyaji H
J Pharmacol Exp Ther; 2005 Jul; 314(1):244-51. PubMed ID: 15798001
[TBL] [Abstract][Full Text] [Related]
3. Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2.
Yoshimura-Uchiyama C; Iikura M; Yamaguchi M; Nagase H; Ishii A; Matsushima K; Yamamoto K; Shichijo M; Bacon KB; Hirai K
Clin Exp Allergy; 2004 Aug; 34(8):1283-90. PubMed ID: 15298571
[TBL] [Abstract][Full Text] [Related]
4. A novel antagonist of prostaglandin D2 blocks the locomotion of eosinophils and basophils.
Royer JF; Schratl P; Carrillo JJ; Jupp R; Barker J; Weyman-Jones C; Beri R; Sargent C; Schmidt JA; Lang-Loidolt D; Heinemann A
Eur J Clin Invest; 2008 Sep; 38(9):663-71. PubMed ID: 18837743
[TBL] [Abstract][Full Text] [Related]
5. The opposing role of two prostaglandin D2 receptors, DP and CRTH2, in human eosinophil migration.
Chiba T; Ueki S; Ito W; Kato H; Kamada R; Takeda M; Kayaba H; Furue M; Chihara J
Ann Allergy Asthma Immunol; 2011 Jun; 106(6):511-7. PubMed ID: 21624751
[TBL] [Abstract][Full Text] [Related]
6. Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP.
Gervais FG; Cruz RP; Chateauneuf A; Gale S; Sawyer N; Nantel F; Metters KM; O'neill GP
J Allergy Clin Immunol; 2001 Dec; 108(6):982-8. PubMed ID: 11742277
[TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharide induces macrophage migration via prostaglandin D(2) and prostaglandin E(2).
Tajima T; Murata T; Aritake K; Urade Y; Hirai H; Nakamura M; Ozaki H; Hori M
J Pharmacol Exp Ther; 2008 Aug; 326(2):493-501. PubMed ID: 18492946
[TBL] [Abstract][Full Text] [Related]
8. A novel antagonist of CRTH2 blocks eosinophil release from bone marrow, chemotaxis and respiratory burst.
Royer JF; Schratl P; Lorenz S; Kostenis E; Ulven T; Schuligoi R; Peskar BA; Heinemann A
Allergy; 2007 Dec; 62(12):1401-9. PubMed ID: 17714552
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic profile of OC000459, a potent, selective, and orally active D prostanoid receptor 2 antagonist that inhibits mast cell-dependent activation of T helper 2 lymphocytes and eosinophils.
Pettipher R; Vinall SL; Xue L; Speight G; Townsend ER; Gazi L; Whelan CJ; Armer RE; Payton MA; Hunter MG
J Pharmacol Exp Ther; 2012 Feb; 340(2):473-82. PubMed ID: 22106101
[TBL] [Abstract][Full Text] [Related]
10. Antagonists of the prostaglandin D2 receptor CRTH2.
Pettipher R; Hansel TT
Drug News Perspect; 2008; 21(6):317-22. PubMed ID: 18836589
[TBL] [Abstract][Full Text] [Related]
11. 11-Dehydro-thromboxane B2, a stable thromboxane metabolite, is a full agonist of chemoattractant receptor-homologous molecule expressed on TH2 cells (CRTH2) in human eosinophils and basophils.
Böhm E; Sturm GJ; Weiglhofer I; Sandig H; Shichijo M; McNamee A; Pease JE; Kollroser M; Peskar BA; Heinemann A
J Biol Chem; 2004 Feb; 279(9):7663-70. PubMed ID: 14668348
[TBL] [Abstract][Full Text] [Related]
12. A dominant role for chemoattractant receptor-homologous molecule expressed on T helper type 2 (Th2) cells (CRTH2) in mediating chemotaxis of CRTH2+ CD4+ Th2 lymphocytes in response to mast cell supernatants.
Gyles SL; Xue L; Townsend ER; Wettey F; Pettipher R
Immunology; 2006 Nov; 119(3):362-8. PubMed ID: 17067313
[TBL] [Abstract][Full Text] [Related]
13. Agonist and antagonist effects of 15R-prostaglandin (PG) D2 and 11-methylene-PGD2 on human eosinophils and basophils.
Cossette C; Walsh SE; Kim S; Lee GJ; Lawson JA; Bellone S; Rokach J; Powell WS
J Pharmacol Exp Ther; 2007 Jan; 320(1):173-9. PubMed ID: 17041009
[TBL] [Abstract][Full Text] [Related]
14. CRTH2 mediates the activation of human Th2 cells in response to PGD(2) released from IgE/anti-IgE treated nasal polyp tissue.
Pérez-Novo CA; Holtappels G; Vinall SL; Xue L; Zhang N; Bachert C; Pettipher R
Allergy; 2010 Mar; 65(3):304-10. PubMed ID: 19839971
[TBL] [Abstract][Full Text] [Related]
15. Possible novel receptor for PGD2 on human bronchial epithelial cells.
Chiba T; Kanda A; Ueki S; Ito W; Yamaguchi K; Kamada Y; Takeda M; Tanigai T; Oyamada H; Kayaba H; Chihara J
Int Arch Allergy Immunol; 2007; 143 Suppl 1():23-7. PubMed ID: 17541272
[TBL] [Abstract][Full Text] [Related]
16. D-type prostanoid receptor enhances the signaling of chemoattractant receptor-homologous molecule expressed on T(H)2 cells.
Sedej M; Schröder R; Bell K; Platzer W; Vukoja A; Kostenis E; Heinemann A; Waldhoer M
J Allergy Clin Immunol; 2012 Feb; 129(2):492-500, 500.e1-9. PubMed ID: 21930295
[TBL] [Abstract][Full Text] [Related]
17. An orally bioavailable small molecule antagonist of CRTH2, ramatroban (BAY u3405), inhibits prostaglandin D2-induced eosinophil migration in vitro.
Sugimoto H; Shichijo M; Iino T; Manabe Y; Watanabe A; Shimazaki M; Gantner F; Bacon KB
J Pharmacol Exp Ther; 2003 Apr; 305(1):347-52. PubMed ID: 12649388
[TBL] [Abstract][Full Text] [Related]
18. Chemoattractant receptor-homologous molecule expressed on Th2 cells activation in vivo increases blood leukocyte counts and its blockade abrogates 13,14-dihydro-15-keto-prostaglandin D2-induced eosinophilia in rats.
Shichijo M; Sugimoto H; Nagao K; Inbe H; Encinas JA; Takeshita K; Bacon KB; Gantner F
J Pharmacol Exp Ther; 2003 Nov; 307(2):518-25. PubMed ID: 12975488
[TBL] [Abstract][Full Text] [Related]
19. 15R-methyl-prostaglandin D2 is a potent and selective CRTH2/DP2 receptor agonist in human eosinophils.
Monneret G; Cossette C; Gravel S; Rokach J; Powell WS
J Pharmacol Exp Ther; 2003 Jan; 304(1):349-55. PubMed ID: 12490611
[TBL] [Abstract][Full Text] [Related]
20. CRTH2 and D-type prostanoid receptor antagonists as novel therapeutic agents for inflammatory diseases.
Schuligoi R; Sturm E; Luschnig P; Konya V; Philipose S; Sedej M; Waldhoer M; Peskar BA; Heinemann A
Pharmacology; 2010; 85(6):372-82. PubMed ID: 20559016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
